SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,808.16 -271.80
( -0.35%)

Global Indices

Nasdaq

53,854.87 63.60
(0.12%)

Dow Jones

7,820.53 51.03
(0.66%)

Hang Seng

68,341.16 817.10
(1.21%)

Nikkei 225

10,757.72 -75.43
(-0.70%)

Forex

USD-INR

95.37 0.00
(0.00%)

EUR-INR

110.01 -0.06
(-0.05%)

GBP-INR

128.81 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Srestha Finvest Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

539217

INE606K01049

1.0006686

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

52.73

EPS(TTM)

Face Value()

Div & Yield %

Back

Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter

Aug 04,2026

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2149.77	1710.72	26
OPM %	15.44	16.42	-
PBDT	319.57	263.88	21
PBT	221.86	190.11	17
NP	173.07	154.38	12

77,808.16 -271.80 ( -0.35%)

53,854.87 63.60 (0.12%)

7,820.53 51.03 (0.66%)

68,341.16 817.10 (1.21%)

10,757.72 -75.43 (-0.70%)

95.37 0.00 (0.00%)

110.01 -0.06 (-0.05%)

128.81 0.00 (0.00%)

0.60 0.00 (-0.04%)